Cargando…

Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis

Detalles Bibliográficos
Autor principal: Habek, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325041/
https://www.ncbi.nlm.nih.gov/pubmed/34331616
http://dx.doi.org/10.1007/s10072-021-05495-6
_version_ 1783731488114606080
author Habek, Mario
author_facet Habek, Mario
author_sort Habek, Mario
collection PubMed
description
format Online
Article
Text
id pubmed-8325041
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-83250412021-08-02 Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis Habek, Mario Neurol Sci Covid-19 Springer International Publishing 2021-07-31 2021 /pmc/articles/PMC8325041/ /pubmed/34331616 http://dx.doi.org/10.1007/s10072-021-05495-6 Text en © Fondazione Società Italiana di Neurologia 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Covid-19
Habek, Mario
Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
title Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
title_full Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
title_fullStr Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
title_full_unstemmed Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
title_short Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis
title_sort chickenpox and asymptomatic covid-19 after first cycle of alemtuzumab for multiple sclerosis
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325041/
https://www.ncbi.nlm.nih.gov/pubmed/34331616
http://dx.doi.org/10.1007/s10072-021-05495-6
work_keys_str_mv AT habekmario chickenpoxandasymptomaticcovid19afterfirstcycleofalemtuzumabformultiplesclerosis